Evidence map›Paper›PMID 34693211›Full record

ReviewMayo Clinic proceedings. Innovations, quality & outcomes2021

Cancer Screening During the COVID-19 Pandemic: A Systematic Review and Meta-analysis.

MacKenzie Mayo, Bindu Potugari, Rami Bzeih, Caleb Scheidel, Carolyn Carrera, Richard A Shellenberger

Open access · goldAbstract readReview
In one paragraph

Review in Mayo Clinic proceedings. Innovations, quality & outcomes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 4 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 4 syntheses or guidelines pooled it, 106 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Implementation of second round of HPV-based screening for cervical cancer in programmatic contexts in Argentina.Revista panamericana de salud publica = Pan American journal of public health · 2025
    Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Survivorship care plans and adherence to breast and cervical cancer screening guidelines among cancer survivors in a national sample.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

MacKenzie MayoInternal Medicine Residency Program, St. Joseph Mercy Ann Arbor Hospital, Ypsilanti, MI.
Bindu PotugariHematology and Oncology Fellowship Program, St. Joseph Mercy Ann Arbor Hospital, Ypsilanti, MI.
Rami BzeihDepartment of Internal Medicine, University of Louisville, Louisville, KY.
Caleb ScheidelResearch Department, St. Joseph Mercy Ann Arbor Hospital, Ypsilanti, MI.
Carolyn CarreraDepartment of Hematology and Oncology, St. Joseph Mercy Ann Arbor Hospital, Ypsilanti, MI.
Richard A ShellenbergerDepartment of Internal Medicine, St. Joseph Mercy Ann Arbor Hospital, Ypsilanti, MI.
Trinity Health Ann Arbor Hospital · USUniversity of Louisville · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to assess the impact of measures designed to mitigate the spread of coronavirus disease 2019 (COVID-19) on worldwide cancer screening. We systematically searched PubMed, Ovid MEDLINE, the Cochrane COVID-19 Study Register, ClinicalTrials.gov, and EMBASE without language restrictions for studies published between January 1, 2021, and February 10, 2021. Studies selected for full-text review contained data on patients screened for any type of cancer during the COVID-19 pandemic and comparison data from a time interval just prior to the pandemic. Data were obtained through dual extraction. All the included studies were assessed for quality and risk of bias. A meta-analysis was performed on 13 studies: 7 on screening mammography, 5 on colon cancer screening, and 3 on cervical cancer screening. Two of our studies reported on more than one type of cancer screening. The screening outcomes were reported as pooled incidence rate ratios using the inverse variance method and random effects models. All studies included in our meta-analysis reported the number of patients screened for cancer in defined time intervals before and during the COVID-19 pandemic. We found that the pooled incidence rate ratios were significantly lower for screening during the COVID-19 pandemic for breast cancer (0.63; 95% CI, 0.53 to 0.77;

Indexed as

COVID-19, coronavirus disease 2019IRR, incidence rate ratio

Identifiers

PMID34693211
PMCPMC8520861
OpenAlexW3207173652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.